President's Message

Barbara Gordon, ASBMB executive director, to retire in 2021

Toni M. Antalis
Nov. 17, 2020

It is with mixed feelings that I am writing to let you know that the American Society for Biochemistry and Molecular Biology’s longtime executive director, Barbara A. Gordon, announced today that she will be retiring in early 2021.

Barbara A. Gordon has been executive director of the ASBMB since 2003.

Barbara has spent just about her entire career at the society, and we couldn’t have asked for a more committed and caring leader. She began working for the Journal of Biological Chemistry in 1972 and went on to manage the society’s meetings and its journals before being appointed executive director in 2003. During her tenure, she oversaw the journals’ transition to online publishing and, most recently, their transition to open access. She also oversaw the formation of new committees and programs, such as the undergraduate degree-accreditation program and certification exam, the IMAGE grant-writing workshop, and the new MOSAIC program for diverse young investigators. Her list of accomplishments is long and impressive.

Barbara has been tremendously supportive and encouraging to all members of our ASBMB community, and we will most certainly miss her. She has freely shared her wisdom, intelligence and humor with all who have had the pleasure of working with her. On behalf of the Council and all who have benefited from working with Barbara, I thank her for her exceptional service to the society and congratulate her on her well-deserved retirement.

The Council will soon begin the search process for a new executive director and will keep you updated on its progress. We will work closely with Barbara, the headquarters staff and the committees to ensure that there is a smooth transition.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Toni M. Antalis

Toni Antalis is a professor of physiology at the University of Maryland School of Medicine, where she is also the associate director for training and education for the Greenebaum Cancer Center and the director of the graduate program in molecular medicine. She began her term as the ASBMB’s president in July 2020.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

How undergrad research catalyzes scientific careers
Essay

How undergrad research catalyzes scientific careers

Aug. 27, 2025

Undergraduate research doesn’t just teach lab skills, it transforms scientists. For Antonio Rivera and Julissa Cruz–Bautista, joining a lab became a turning point, fostering critical thinking, persistence and research identity.

Simcox and Gisriel receive mentoring award
Member News

Simcox and Gisriel receive mentoring award

Aug. 25, 2025

They were honored for contributing their time, knowledge, energy and enthusiasm to mentoring postdocs in their labs.

ASBMB names 2025 Marion B. Sewer scholarship recipients
Society News

ASBMB names 2025 Marion B. Sewer scholarship recipients

Aug. 21, 2025

Ten undergraduates interested in biochemistry and molecular biology will each receive $2,000 toward their tuition and related educational costs.

Attie named honorary professor
Member News

Attie named honorary professor

Aug. 18, 2025

This award includes $100,000 of research funding and recognizes faculty who have made major contributions to the advancement of knowledge through their research, teaching and service activities.

Meet the 2025 SOC grant awardees
Outreach

Meet the 2025 SOC grant awardees

Aug. 15, 2025

Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.